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CybridLeber's hereditary optic neuropathy is a maternally inherited optic atrophy caused by mitochondrial DNA
point mutations. Previous epidemiological studies have shown that individuals from mitochondrial genetic
backgrounds (haplogroups) J/Uk and H have a higher and a lower risk, respectively, of suffering this disorder.
To analyze the bases of these associations at cellular and molecular levels, functional studies with cybrids
provide high quality evidence. Cybrids from haplogroup J contain less mitochondrial deoxyribonucleic acid
(DNA) and ribonucleic acid (RNA) and synthesize a smaller amount of mitochondrial DNA-encoded polypep-
tides than those from haplogroup H. Haplogroup J cybrids also display lower oxygen consumption, mitochon-
drial inner membrane potential and total adenosine‐5′‐triphosphate (ATP) levels. Moreover, mitochondrial
DNA levels correlate with many parameters of the oxidative phosphorylation system. These results suggest
that the mitochondrial DNA amount determines oxidative phosphorylation capacity and, along with other
recently published observations, support the possibility that mitochondrial DNA levels may be responsible
for the bias of the disorder toward males, for the incomplete penetrance of mutations causing Leber's hered-
itary optic neuropathy and for the association of the disease with particular mitochondrial DNA haplogroups.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Leber's hereditary optic neuropathy (LHON, OMIM 535000) is the
most frequent mitochondrial DNA (mtDNA) disease. The endpoint
of the disease is an optic atrophy associated with loss of central vi-
sion. Most LHON patients harbor one of the three primary mtDNA
point mutations in genes from respiratory complex I (CI): m.3460G>
A/MT-ND1/p.MT-ND1:A52T, m.11778G>A/MT-ND4/p.MT-ND4:R340H
and m.14484T>C/MT-ND6/p.MT-ND6:M64V. While the pathomechan-
isms for these mutations are beginning to unravel [1], why mainly
males are affected with LHON and why many homoplasmic mutant
maternal relatives do not develop the disease is still unknown.
Since the middle of the 1990s, different studies have found epide-
miologic associations between LHON and particular phylogenetically
related mtDNA genotypes, known as mtDNA haplogroups. In 1997,
analyzing North American, German, Finish and Italian white patients,
four different groups found that haplogroup J was overrepresented in
LHON patients who harbored the pathologic mtDNA mutations
m.11778G>A or m.14484T>C [2–5]. The risk of visual failure was
also increased in haplogroup Uk patients who had m.3460G>A [6].uímica, Biología Molecular y
177, 50013-Zaragoza, Spain.
l rights reserved.In contrast, haplogroup H appears to be a LHON resistance factor
[7]. Combined, these results suggest that single nucleotide polymor-
phisms (SNPs) deﬁning these haplogroups contribute to the patho-
logic phenotype.
Because it is impossible to control all environmental factors that
affect humans, epidemiological studies inherently involve a heteroge-
neous subject pool. Moreover, nuclear DNA (nDNA) represents
99.9995% of the human genome and, therefore, many nuclear SNPs
could affect the results of epidemiological studies onmtDNA. These dis-
advantages are only partially counteracted by increasing the sample
size, and this is a difﬁcult task for rare diseases such as LHON [8]. To
overcome such problems, and analyze the bases of these associations
at cellular and molecular levels, an appropriate model such as the
transmitochondrial cell line, cytoplasmic hybrid or cybrid model [9]
was required. Cybrid cell lines share the same nuclear genetic back-
ground and environmental conditions but differ in their mtDNA geno-
type. Using this approach, we have recently shown that mtDNA and
mtRNA levels, mitochondrial protein synthesis, cytochrome oxidase
activity and amount, normalized oxygen consumption, mitochondrial
inner membrane potential and growth capacity are different between
cybrids of haplogroup H and Uk [10].
Because haplogroups J/Uk and H are susceptibility and resistance
factors, respectively, for LHON disease and that haplogroups H and
Uk are different from a biochemical phenotype point of view, we
used the cybrid model to investigate whether epidemiologic
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events as those of haplogroup Uk. Our results conﬁrm that the
mtDNA levels determine, in a large part, the oxidative phosphoryla-
tion (OXPHOS) capacity of the cell and that, if the lower amount of
mtDNA in haplogroup J and Uk cybrids mirrors an individual's situa-
tion, then this lower amount might be responsible for higher suscep-
tibilities of individuals from these haplogroups to develop LHON.
2. Materials and methods
2.1. Biological samples and growth conditions
After winning the approval of the Ethics Committee of the Govern-
ment of Aragón (Acta n817/2008) and securing signed informed con-
sent from the healthy volunteers, blood was obtained, and platelets of
ﬁve and nine individuals from mtDNA haplogroups H and J, respec-
tively, were used to build cybrids with the osteosarcoma 143B TK−
rho0 206 nuclear background from Attardi's laboratory.
Experiments were performed with cell lines grown in Dulbecco's
modiﬁed eagle medium (DMEM) containing glucose (4.5 g/l), pyru-
vate (0.11 g/l) and fetal bovine serum (FBS) (5%) without antibiotics.
When cells were grown with an antioxidant, 5 mM of N-acetyl cyste-
ine (NAC) was used in the culture medium.
2.2. Molecular–genetic analysis
Samples from the volunteers were genetically characterized by
performing PCR-RFLP for mitochondrial haplogroup-deﬁning SNPs
in the coding region and sequencing the hypervariable regions I and
II. The complete mtDNA sequences were obtained by using the Big-
Dye Terminator v 3.1 Cycle Sequencing Kit (Applera Rockville, MD,
USA) and an ABI Prism 3730xl DNA analyzer (Applied Biosystems,
Foster City, CA, USA). The mtDNA content was measured by the
qPCR method using an Applied Biosystems StepOneTM Real-Time
PCR System Thermal Cycling Block (Applied Biosystems). The
mtDNA levels were determined in triplicate in three to six indepen-
dent experiments [10].
To assess the mRNA levels, total RNA was isolated from exponen-
tially growing cells using a RNA isolation kit (NucleoSpin® RNA II)
from Macherey–Nagel according to the manufacturer's protocol;
2.5 μg of total RNA was reversed-transcribed into cDNA with a high
capacity cDNA reverse transcription kit (Applied Biosystems), using
the manufacturer's conditions. The mRNA levels of manganese super-
oxide dismutase (MnSOD), 6-phosphofructo-1-kinase-L (PFKL) and
mtRNAs were determined in triplicate in two independent experi-
ments by RTqPCR using the One-Step Real-Time system (Applied Bio-
systems). The mRNA levels of mitochondrial DNA polymerase subunit
B (POLG2), TWINKLE helicase, single stranded DNA-binding protein
(mtSSB), mitochondrial RNA polymerase (POLRMT), mitochondrial
transcription factor B2 (TFB2M) and mitochondrial termination factor
(MTERF) were determined using probes described previously [11].
The expression levels were normalized using the 18S rRNA reference
gene. The comparative Cqmethod was used for relative quantiﬁcation
of gene expression as described by the real-time PCR machine manu-
al. Differences in the Cq values (dCq) of the transcript of interest and
the reference gene were used to determine the relative expression of
the gene in each sample. The dCq method was used to calculate fold
expression. StepOne software version 2.0 (Applied Biosystems) was
used for data analysis [10].
2.3. MtDNA-encoded protein synthesis
The mitochondrial protein synthesis was analyzed as previously
described with minor modiﬁcations [10]. Electrophoresis was per-
formed with a Protean II xi system (BIORAD). As a load control, we
dyed the gel for 15 min with ﬁxing solution (30% methanol, 10%acetic acid) plus 0.025% of Brilliant Blue R (Coomassie Blue)
(Sigma). Then, the gel was washed several times with a 50% metha-
nol, 10% acetic acid solution and left overnight in a ﬁxing solution.
Finally, it was treated for 20 min with the Amplify solution (AMER-
SHAM), dried and used for autoradiography. The band intensities
from appropriate exposures of the ﬂuorogram from at least two inde-
pendent gels were quantiﬁed by densitometric analysis with the
Gelpro analyzer v 4.0. Three bands, corresponding to p.MT-CO1,
p.MT-ND2 and p.MT-ND3 (upper, middle and lower parts of the gel,
respectively) polypeptides were selected to quantiﬁcation.
2.4. Oxygen consumption and respiratory complex activities and levels
Oxygen consumption was analyzed using the high-resolution oxy-
graph OROBOROS®. To reduce experimental manipulation, such as cell
permeabilization, and its effects on the ﬁnal results, intact cells were
used. Exponentially growing cells were collected by trypsinization,
washed, counted and resuspended at 1.5×106 cells/ml. Endogenous,
leaking (with oligomycin added at 49 nM) and uncoupled (with FCCP
added at 1.2 μM) respiration analyses were performed. To correct for
the oxygen consumption that is not due to an electron transport chain
(ETC), respiration inhibition by KCN was performed. Each cell line was
measured three to four times in DMEM glucose. Respiration was mea-
sured at 37 °C with chamber volumes set at 2 ml. The software DatLab
(Oroboros Instrument, Innsbruck, Austria)was used for data acquisition
(1 s time intervals) and analysis [10].
Mitoproﬁle® Human Complex IV Activity and Quantity from
Mitosciences (Invitrogen) was used according to the manufacturer's
instructions for the determination of CIV activity and levels. The enzy-
matic activities of respiratory complex II (CII) and IV (CIV) and citrate
synthase (CS) were assayed in a NovoStar MBG Labtech microplate
instrument [10].
2.5. Determination of mitochondrial inner membrane potential and
surface
The determination of mitochondrial inner membrane potential
(MIMP) was done in triplicate in at least three independent experi-
ments using 3,3′-dihexyloxacarbocyanine [DiOC6(3)]. Mitochondrial
inner membrane surface (MIMS) was measured, based on the quanti-
ty of cardiolipin, four times in three independent experiments by
using nonyl-acridine orange (NAO). A Beckman Coulter Cytomics
FC500 cytometer was used for measurements of intracellular ﬂuores-
cence [10].
2.6. Determination of ATP levels
ATP levels were measured four times in three independent exper-
iments using the CellTiter-Glo® Luminiscent Cell Viability Assay (Pro-
mega) according to the manufacturer's instructions. Brieﬂy, 20,000
cells/well were seeded 10–12 h before measurement. Then, cells
were washed twice with PBS and incubated for 6 h in a record solu-
tion with either 5 mM glucose, 5 mM glucose plus 2.5 μg/ml oligomy-
cin (glycolytic ATP generation), 5 mM 2-deoxy-D-glucose plus 1 mM
pyruvate (oxidative ATP production) or 5 mM 2-deoxy-D-glucose
plus 1 mM pyruvate plus 2.5 μg/ml oligomycin. Cells were lysed, and
lysates were incubated with the luciferin/luciferase reagents. Samples
were measured using a NovoStar MBG Labtech microplate lumin-
ometer, and the results referred to the protein quantity [10].
2.7. Statistics analysis
The statistical package StatView 6.0 was used to perform all the sta-
tistics. Data formean, standard deviation and sample size are presented.
The normal distribution was checked by the Kolmogorov–Smirnov test
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P-values of b0.05 were considered statistically signiﬁcant.
3. Results
To analyze haplogroup J OXPHOS function attempting to avoid
the introduction of clonal effects, we built nine different cybrids in
the nuclear background of osteosarcoma 143B cells. The epidemio-
logical differences described in the Introduction have been found
in European or European-descended individuals, and the major
European subhaplogroups J are J1c and J2. To minimize phenotypic
effects due to subhaplogroup-deﬁning SNPs, we built the same num-
ber of J1c- and J2-derived cybrids (Supplementary Fig. 1). We also
included one sample from J1b, a less frequent subhaplogroup J in
European populations [12]. The same ﬁve haplogroup H cybrids
that we used to evaluate haplogroup Uk OXPHOS function [10]
were also used here as the reference group; these transmitochon-
drial cell lines included haplotypes of three subhaplogroups H,
two of which are widely represented in Europe.
3.1. MtDNA and mtRNA levels and mitochondrial protein synthesis are
lower in cybrids from haplogroup J
It has been reported that one of the mtDNA variants that distin-
guishes haplogroups H and J (m.295C>T/MT-DLOOP) increases mito-
chondrial transcription factor A (TFAM) binding and mtDNA copy
numbers. In fact, cybrids from haplogroup J were found to have two
times more mtDNA than those of haplogroup H [13]. In contrast to
the previous results, we observed that mtDNA levels were in fact
11% lower in cybrids from haplogroup J than in those of haplogroup
H (Fig. 1A). Possible explanations for this discrepancy could be differ-
ent nDNA–mtDNA interactions due to distinct nuclear donor rho0 cell
lines (lymphoblastoid Wal2A versus osteosarcoma 143B) or differ-
ences in mitochondrial genetic background (1 J1, 1 J1b2, 1 H1, 2 H6
and 2 H* versus 1 J1b1, 4 J1c, 4 J2, 3 H1, 1 H5 and 1 H13). Because
cybrids from haplogroup J did not have other SNPs in sequences in-
volved in mtDNA replication, we reasoned that some other mecha-
nism was responsible for the differences in mtDNA levels.Fig. 1. mtDNA quantity and expression levels of genes associated with mtDNA replica-
tion. White and black bars represent mean values for cybrids H and J, respectively. The
mean value for H cybrids has been set to 100%. A. mtDNA levels. The mean value for H
cybrids not treated with NAC was set to 100%. *P=0.0007. B. MnSOD mRNA levels.
C. mRNA levels of different genes involved in mtDNA replication.It has been reported that high reactive oxygen species (ROS) levels
enhanced mtDNA replication [14] and that the antioxidant NAC can de-
crease mtDNA levels [15]. The mRNA levels of the antioxidant enzyme
MnSOD were the same in cybrids H and J (Fig. 1B), suggesting that the
difference inmtDNA levels between the cybrids probablywas not caused
by differences in ROS levels. However, we did ﬁnd that cybridH'smtDNA
levels were signiﬁcantly reduced by treatment with NAC, though this
compound left cybrid J's mtDNA levels largely unaltered (Fig. 1A).
It has been suggested that NAC may not function to scavenge ROS
but rather to interfere with the formation of disulﬁde bonds involved
in functional redox switches and signaling pathways [16]. If this was
the case, it is possible that a NAC-sensitive regulatory pathway control-
ling mtDNA levels is differentially affected in the cybrids of the two
different haplogroups. It has already been shown that expression levels
of several nuclear genes are different between cybrids H and J [17,18]
and that NAC affects the levels of some of them [19]. To check for po-
tential differences in the expression of mtDNA replication genes, we
measured mRNA levels for POLG2, TWINKLE, mtSSB and POLRMT
[11]. However, we did not ﬁnd differences between cybrids from the
two haplogroups (Fig. 1C). Thus, NAC either acts directly at the protein
level or the effects we observe involve some other cellular pathway.
After evaluating cybrid mtDNA levels, we then turned our atten-
tion to mtDNA gene expression. The levels of all mtRNAs were de-
creased in cybrids from haplogroup J; however, the differences for
16S rRNA, p.MT-ND4/ND4L, p.MT-ND6, p.MT-CO1, p.MT-CO3 and
p.MT-ATP6/8 were the only ones that were statistically signiﬁcant
(Fig. 2A). The mean total mtRNA levels of cybrids from haplogroup
J were 18% lower than those of haplogroup H (Fig. 2B). These levels
were similarly lower for cybrids J RNAs from the three mtDNA tran-
scription units (Fig. 2C); moreover, RNA levels of the three tran-
scription units showed a signiﬁcant positive correlation (r≥0.77,
P≤0.0007). None of the genetic differences between cybrids H and
J are in sequences involved in mtDNA transcription, and neither
did the analysis of mRNA levels for proteins involved in mtDNA
transcription, such as POLRMT, TFB2M and MTERF, show differences
between cybrids H and J (Fig. 2D). Therefore, these results point to a
general mechanism controlling these mtRNA levels. The relationship
between mtDNA and mtRNA levels has been frequently reported
[10,20–24], and it has been previously shown that p.MT-ATP6 and
p.MT-CO1 mRNA levels correlate signiﬁcantly with mtDNA copy
number [24,25]. In our cybrids, RNA levels from transcription units
L and H1 correlate signiﬁcantly with mtDNA levels (r≥0.57,
P≤0.031), a result that further supports the interpretation that
lower cybrid J mtRNA levels are due to reduced mtDNA amounts.
To determine the effect of lower mtRNA levels in J cybrids, we
studied the synthesis of mtDNA-encoded polypeptides. The analysis
of mitochondrial translation products showed a signiﬁcant decrease
in mitochondrial protein synthesis in J cybrids (Fig. 3). Only
m.2706A>G, a mutation in the 16S rRNA gene (MT-RNR2), could ex-
plain the lower mitochondrial protein synthesis in J cybrids. However,
we found that mtDNA amount and RNA levels for genes from tran-
scription unit H1 were signiﬁcantly correlated with mitochondrial
protein synthesis (r≥0.62, P≤0.016). These correlations, along with
previous observations [10,23], suggest that lower mitochondrial
nucleic acid levels are probably responsible for the lower synthesis
of mtDNA-encoded polypeptides.
3.2. The mitochondrial mass of haplogroups H and J cybrids is similar
The lower mtDNA and mtRNA levels and a decreased mitochon-
drial protein synthesis in J cybrids could result from having fewer
mitochondria. To check for potential differences in the cell fraction
occupied by mitochondria, we determined the speciﬁc activity of
CS, a nDNA-encoded mitochondrial matrix enzyme that it is fre-
quently used as a marker for the mitochondrial number or size.
We also measured the speciﬁc activity of CII, a nDNA-encoded
Fig. 2.mtRNA quantity and expression levels of genes associated with mtDNA transcription. White and black bars represent mean values for cybrids H and J, respectively. The mean
value for H cybrids was set to 100%. *P≤0.05. A. mtRNA levels. B. Total mtRNA levels. C. Levels of mtRNA products according to transcription unit. D. mRNA levels of genes involved
in mtDNA transcription.
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periments, however, did not reveal any differences between H and J
cybrid values for the parameters tested (Fig. 4A and B). Therefore,
the lower mitochondrial nucleic acid and protein levels in J cybrids
are not due to having fewer mitochondria.
It has recently been found that mtDNA levels correlate with CIV
activity [26,27]. Although we demonstrate that CIV amount and activ-
ity are indeed correlated (r=0.81, P=0.0002), there were no signif-
icant differences in these values between both haplogroups (Fig. 4C).
Interestingly, a general tendency for a faster recovery and higher ﬁnal
CIV levels after treatment with doxycycline were previously observed
in haplogroup J LHON mutant cybrids [28]. These results suggest the
possibility that the mtDNA genetic background of J cybrids somehow
inﬂuences CIV assembly or stability. Such an observation could be the
reason that the CIV of H and J cybrids is of similar quantity and activ-
ity even though mitochondrial gene expression in J cybrids is lower.
3.3. Oxygen consumption and mitochondrial inner membrane potential
are lower in cybrids from haplogroup J
The absence of differences in CIV activity and quantity between
cybrids H and J does not rule out the possibility for differences inFig. 3.mtDNA-encoded protein levels. White and black bars represent mean values for
cybrids H and J, respectively. The mean value for H cybrids was set to 100%. *P=0.005.other respiratory complexes and OXPHOS function. In fact, it has
been shown that mtDNA levels also correlate with respiratory com-
plex III (CIII) activity [26]. ETC is the main oxygen consumer in the
cell. Oxidation of substrates generates reducing power and these elec-
trons will travel through the ETC complexes (CI–IV), which ultimately
lead to the reduction of oxygen to water. We therefore measured ox-
ygen consumption of our cybrids and found signiﬁcant differences inFig. 4. Cell fraction occupied by mitochondria. White and black bars represent mean
values for cybrids H and J, respectively. The mean value for H cybrids was set to
100%. A. Speciﬁc activities of nDNA-encoded mitochondrial enzymes. B. MIMS. C. CIV
speciﬁc activities and levels.
Fig. 5. Oxygen consumption and MIMP. White and black bars represent mean values for cybrids H and J, respectively. A. Oxygen consumption. E, L and U stand for endogenous,
leaking and uncoupled respiration, respectively. The mean value for E respiration in H cybrids was set to 100%. *P=0.01. B. MIMP. The mean value for H cybrids was set to
100%. *P=0.006.
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min/cell) (Fig. 5A). Interestingly, we have previously observed that
healthy Spanish males of haplogroup J have signiﬁcantly lower
VO2max than non-J individuals [29] and H individuals, in particular
[30]. Moreover, it has been reported that mtDNA levels correlate
with VO2max [21] and with cell oxygen consumption [31,32]. Despite
having similar CIV values, the different cybrids showed a signiﬁcant
positive correlation between CIV speciﬁc activity and endogenous
respiration (r=0.65, P=0.009).
Respiratory ETC is coupled to the pumping of protons into the
intermembrane space, a process that generates an electrochemical
gradient across the mitochondrial inner membrane. This gradient
can, by feedback, inhibit the proton pumping and, as a consequence,
oxygen consumption. To rule out indirect effects of the electrochem-
ical gradient on oxygen consumption, we treated the cybrids with the
ATP synthase inhibitor oligomycin (leaking respiration) or the uncou-
pler FCCP (uncoupled respiration), compounds that, respectively in-
crease or decrease the electrochemical gradient. This analysis,
however, showed that uncoupled respiration was not signiﬁcantly
lower in J cybrids. Interestingly, others have described a correlation
between mtDNA levels and uncoupled oxygen consumption in
mouse cybrids [33]. Leaking respiration was signiﬁcantly lower in
cybrids from haplogroup J (Fig. 5A). There was a positive correlation
between CIV speciﬁc activity and leaking respiration (r=0.60,
P=0.020) as well as between endogenous and leaking or uncoupled
respiration (r≥0.65, P≤0.010). Thus, the lower oxygen consumption
of J cybrids was apparently not due to a higher electrochemical gradi-
ent. In fact, MIMP of cybrids from haplogroup J was signiﬁcantly
lower (Fig. 5B), and MIMP was signiﬁcantly correlated with mtDNA
levels, endogenous respiration and leaking respiration (r≥0.56,
P≤0.042). It is possible that the lower MIMP of J cybrids results sec-
ondarily from reduced proton pumping, because of a lower electron
ﬂow rate through the ETC complexes, which in turn causes loweredFig. 6. ATP and PFKL mRNA levels. A. ATP levels. G, DGP, DGPO, GO are abbreviations for glu
2.5 μg/ml oligomycin and glucose plus 2.5 μg/ml oligomycin, respectively. The mean value fo
for H cybrids was set to 100%. *P=0.006.oxygen consumption. Supporting this interpretation, rotenone inhibi-
tion of CI from osteosarcoma 143B cells inhibited cell respiration and
decreased MIMP [34]. Moreover, a mutation in the MT-ND5 gene of
osteosarcoma 143B cybrids resulted in decreases in both respiration
and MIMP [35].
Between cybrids H and J, there are nine different SNPs in mtDNA
protein-coding genes that could potentially explain the differences
we observe in oxygen consumption. While four of the SNPs are syn-
onymous changes (m.7028C>T, m.11251A>G, m.11719G>A and
m.12612A>G), three of the non-synonymous SNPs affect CI subunits
(m.4216T>C/p.MT-ND1:Y304H, m.10398A>G/p.MT-ND3:T114A and
m.13708G>A/p.MT-ND5:A458T). It was shown that a cybrid harbor-
ing threonine at p.MT-ND3 residue 114 (as in H cybrids) had in-
creased CI activity [36] and Escherichia coli harboring histidine at
NuoH residue 316 (homologous to human p.MT-ND1 residue 304)
had a markedly decreased hexamine ruthenium reductase activity,
indicating that structural integrity of CI was affected [37]. The two
other non-synonymous SNPs are in p.MT-CYB (m.14766C>T/p.MT-
CYB:T7I and m.15452C>A/p.MT-CYB:L236I), and it has been sug-
gested that Thr7 in p.MT-CYB, like in H cybrids, can increase the efﬁ-
ciency of the Q-cycle and the ETC overall [38].
3.4. ATP levels are also lower in cybrids from haplogroup J
Because mitochondrial ATP synthesis is dependent on MIMP, we
decided to measure ATP levels in our cybrids and found that ATP
levels were signiﬁcantly lower in cybrids from haplogroup J when
grown in the presence of glucose (Fig. 6A). Under these conditions,
there was also a signiﬁcant correlation between ATP levels and
MIMP (r=0.80, P=0.007). In contrast, we did not ﬁnd any difference
in ATP levels when the cybrids were grown in deoxyglucose with py-
ruvate, a glycolytic inhibitor and a substrate that is consumed by the
OXPHOS system. ATP levels were also signiﬁcantly different when thecose, 2-deoxy-glucose plus 1 mM pyruvate, 2-deoxy-glucose plus 1 mM pyruvate and
r H cybrids in glucose was set to 100%. *P=0.003. B. PFKL mRNA levels. The mean value
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sults therefore suggest that J cybrids are defective in some aspect of
glycolysis. To test this hypothesis, we ﬁrst analyzed the mRNA levels
of the main glycolytic regulator enzyme PFKL. Contrary to our expec-
tations, PFKL levels were signiﬁcantly higher in J cybrids (Fig. 6B), an
effect that probably results from a compensatory response. However,
it has been suggested that glycolytic ATP can supply energy for main-
taining MIMP [35,39]. Therefore, it is possible that the lower ATP
levels in J cybrids is the combined result of an incomplete compensa-
tory glycolytic response and the increased demand for ATP needed to
maintain MIMP. Because glycolytic enzymes are nDNA-encoded, this
result also suggests that OXPHOS differences due to mtDNA SNPs
can inﬂuence the expression of nuclear genes, as has been shown pre-
viously by others [40].
4. Discussion
The correlations found between mtDNA levels and many other
OXPHOS parameters, such as mtRNA levels, mtDNA-encoded protein
amount, respiratory complex activities, oxygen consumption and
MIMP, conﬁrm that mtDNA amount largely determines the OXPHOS
function. Cybrids from haplogroup Uk [10] and haplogroup J contain
less mtDNA than those from haplogroup H. Considering that the nu-
clear genetic background and culture conditions are the same in all
these cybrids, the differences between themmust be due to particular
mtDNA SNPs. Because none of the mtDNA SNPs examined were in se-
quences involved in mtDNA replication and because mtDNA encodes
only OXPHOS proteins, it is likely that the lower mtDNA amounts we
observe are the result of an indirect OXPHOS effect due to other
mtDNA SNPs. OXPHOS is a metabolic pathway involved in many cell
functions, including the regulation of cell red-ox state and the levels
of ROS, calcium and ATP. These compounds act as second messengers
that trigger retrograde signaling responses [41,42]. Thus, the mtDNA
genotype must be able to provoke differences in these parameters.
In support of this hypothesis, it has been shown that intracellular cal-
cium dynamics are different in cybrids from mtDNA haplogroups N
and non-N [43]. Similar to our study, it was recently reported that
ATP levels were higher in CD4+ cells from haplogroup H versus
non-H patients suffering from Huntington disease [44]. Therefore,
these differences in second messengers might alter some of the
many cellular pathways regulated by these compounds.
One of the ﬁve SNPs that differentiate haplogroups J and Uk from
haplogroup H is located in the mtDNA control region but does not
affect sequences that are functionally important. While two of the
other SNPs are synonymous, the remaining two, m.2706A>G/MT-
RNR2 and m.14766C>T/MT-CYB/p.MT-CYB:T7I, are not. In cybrids
Uk [10] and J, these latter two SNPs are suggested to indirectly reduce
mtDNA, mtRNA and mitochondrial protein levels as well as MIMP. Al-
ternatively, it is possible that the OXPHOS differences we observe are
instead determined by SNPs deﬁning haplogroups J1c, J2 and Uk.
Haplogroups Uk and J1c share a non-synonymous SNP in the cyto-
chrome b gene (m.14798T>C/p.MT-CYB:F18L), while haplogroup J2
is deﬁned by a different amino acid change in this protein
(m.15257G>A/p.MT-CYB:D171N). Interestingly, such a scenario in
which J1c and J2 were the key OXPHOS determinants would explain
why haplogroup J and LHON are not correlated in Iran [45], as the
major subhaplogroup J in this region is J1b [46]. The haplogroup J1b
is not deﬁned by amino acid changes in cytochrome b, and cybrids
from this haplogroup have higher mtDNA levels than those from hap-
logroup H [13].
Our results suggest that individuals from haplogroups Uk [10], J1c
and J2 are more susceptible to LHON because they have reduced
OXPHOS capacity, which results in part from lower mtDNA levels.
The mtDNA amounts may also explain why LHON is more highly
prevalent in males. It has recently been reported that estrogens can
increase mtDNA, mtRNA and mtDNA-encoded polypeptide levelsand enhance oxygen consumption and ATP levels in a glucose medi-
um [47]. Moreover, mtDNA levels are lower in LHON-affected individ-
uals as compared to their unaffected homoplasmic mutant maternal
relatives [48]. Thus, a complete compensatory response could be
achieved by increasing mtDNA amounts. According to this model,
individuals incapable of increasing mtDNA amounts sufﬁciently will
develop LHON, a relationship that could very well explain why
LHON has incomplete penetrance. Environmental factors precipitate
the loss in vision and contribute to explain the marked incomplete
penetrance of LHON. A strong and consistent association between
loss in vision and smoking has recently been reported in LHON pedi-
grees [49], and it has been observed that smokers have fewer copies
of mtDNA per nuclear genome [50].
Our results conﬁrm that ancient, highly frequent and inherited
mtDNA genetic variants, such as those deﬁning mtDNA haplogroups,
differently affect OXPHOS function and human health. However,
recent, rare and somatic mtDNAmutations can also alter this function
and manifest phenotypical effects in the organism [33]. Therefore, an
important part of our susceptibility to different pathologies appears
to be mtDNA-mediated.
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